Separate acute from chronic, and put a boundary on duration If someone is intent on using it, the least risky scenario is short-term use around a clearly defined acute injury window, not ongoing use for months for chronic pain
Global burden of metabolic dysfunction-associated steatotic liver disease
How are IV treatments for men different from treatments for women
Currently, there are clinical studies using AAV vectors to transfect sarcoplasmic/endoplasmic reticulum Ca (2+)-ATPase (SERCA2a) to treat heart failure [255, 256]
In 2023, 25% of self-funded health plans incorporate weight loss treatments, a figure anticipated to jump to 43% in 2024
Patrick Stone, a former FDA inspector, said using ingredients not intended for drugs is a huge deal